Rare Laryngeal Leiomyosarcoma Successfully Treated with Surgery and Adjuvant Chemotherapy
BUFFALO, NY – May 13, 2026 – A new #casereport was #published in Volume 17 of Oncotarget on May 4, 2026, titled “Laryngeal leiomyosarcoma: A...
Radio and PodcastLive Radio & Podcasts
Science & Medicine
Oncotarget
Traditional scholarly journal with open free-access. Topics on Oncology, Aging, Pathology, Immunology, Microbiology, Autophagy, Cell Death, and Chromosome
Oncotarget Podcast Guide
Listen to Oncotarget, a Science & Medicine podcast by Oncotarget Podcast. Stream 504 episodes in English, follow new audio stories, and play episodes online on Radio and Podcast.
Show Topic
Browse this show under Science & Medicine podcasts.
Episodes
20 episodes are loaded now from a catalog of 504. More episodes can be opened from this page.
Discover More
Explore Science & Medicine podcasts, India podcasts and English podcasts.
Episodes
20 of 504 episodes
Agentic AI Systems May Transform Nutritional Care in Oncology
BUFFALO, NY – May 11, 2026 – A new #editorial was #published in Volume 17 of Oncotarget on May 4, 2026, titled “Artificial intelligence in n...
Rare Dual-Mutation GIST Responds to Targeted Therapy, Challenging Established Tumor Biology
BUFFALO, NY – May 6, 2026 – A new #casereport was #published in Volume 17 of Oncotarget on May 4, 2026, titled “Small bowel GIST harboring c...
Mapping the Hidden Structure of Glioma Research: What Are We Missing?
Glioma research has evolved rapidly over the past decade, driven by breakthroughs in molecular biology, imaging technologies, and computatio...
Targeted Therapies Drive Long-Term Decline in Multiple Myeloma Mortality in the U.S.
BUFFALO, NY – April 29, 2026 – A new #research paper was #published in Volume 17 of Oncotarget on April 28, 2026, titled “Targeted therapeut...
SCD1 Inhibition Strategy Shows Potent Synergy with Regorafenib and Metformin in Tumor Cell Killing
Cancer has long been understood through a variety of biological frameworks, including genetic mutations, dysregulated signaling pathways, an...
Epigenetic Dysregulation of PDX1 Drives Prostate Cancer Progression
BUFFALO, NY – April 15, 2026 – A new #research paper was #published in Volume 17 of Oncotarget on March 31, 2026, titled “Epigenetic dysregu...
Cancer Care in Conflict Zones Remains Critically Neglected
BUFFALO, NY – April 13, 2026 – A new #review was #published in Volume 17 of Oncotarget on March 31, 2026, titled “Cancer without borders: Po...
Oncotarget Editorial Highlights Advances in Scientific Integrity and Publishing Transparency
BUFFALO, NY – April 10, 2026 – A new #editorial perspective was #published in Volume 17 of Oncotarget on April 8, 2026, titled “Oncotarget:...
CREB5: A Master Regulator of Stem Cell-Like Programs in Prostate Cancer Progression
Androgen receptor (AR) signaling has long been the central driver of prostate cancer progression and the primary target of therapies for adv...
Adjuvant PD-1/PD-L1 Inhibitors Show Efficacy but Highlight Safety Considerations in Solid Cancers
BUFFALO, NY – April 7, 2026 – A new #research paper was #published in Volume 17 of Oncotarget on March 31, 2026, titled “Efficacy and safety...
Bibliometric Mapping Reveals the Evolution of Glioma Classification Research
BUFFALO, NY – April 6, 2026 – A new #review was #published in Volume 17 of Oncotarget on March 31, 2026, titled “Bibliometric mapping of gli...
The SCD1 Inhibitor Aramchol, Regorafenib, and Metformin Combine to Kill Uveal Melanoma Cells
BUFFALO, NY – March 31, 2026 – A new #research paper was #published in Volume 17 of Oncotarget on March 27, 2026, titled “The SCD1 inhibitor...
Predicting Colorectal Cancer Survival: How Machine Learning Combines Clinical and Biological Clues
Colorectal cancer (CRC) ranks among the most common and lethal cancers worldwide, accounting for approximately 10% of all cancer diagnoses....
CREB5 Linked to Stem Cell-Like Programs That Promote Prostate Cancer Progression
BUFFALO, NY – March 24, 2026 – A new #research paper was #published in Volume 17 of Oncotarget on March 17, 2026, titled “CREB5 regulates st...
Impact Journals to Participate at AACR Annual Meeting 2026 in San Diego
BUFFALO, NY – March 16, 2026 – Impact Journals (publisher of Aging-US, Oncotarget, Oncoscience, and Genes & Cancer), is pleased to announce...
CAR-T Cell Therapy: A Revolutionary Approach to Cancer Treatment
Cancer treatment has long been a battle of attrition—surgery, radiation, and chemotherapy have saved countless lives, but for patients with...
mRNA COVID-19 Vaccination and Cancer Risk: A Case-Based Review
The rapid development and global deployment of mRNA vaccines for COVID-19 represented a landmark achievement in public health. However, the...
Next-Generation CAR-T Designs That Could Transform Cancer Treatment
BUFFALO, NY – February 25, 2026 – A new #editorial perspective was #published in Volume 17 of Oncotarget on February 20, 2026, titled “CAR-T...
Researchers Question Editorial Bias in COVID-19 Vaccine Debate
BUFFALO, NY – February 16, 2026 – A new #commentary was #published in Volume 17 of Oncotarget on February 6, 2026, titled “Censorship in sci...
Questions About Oncotarget
Where can I listen to Oncotarget episodes?
You can listen to Oncotarget episodes online on Radio and Podcast. Open an episode and the site player will stream the available audio.
What is Oncotarget about?
Oncotarget is listed as a Science & Medicine show. The show language is listed as English.
How many Oncotarget episodes are listed?
This page lists 504 episodes for Oncotarget. More episodes are available from the View more button when the list continues.